로딩 중…
StockDiggingStockDigging

Elanco Animal Health Incorporated

ELAN· NYSE
$22.41-1.43%
2026-09-18

Financials

Valuation Metrics

Elanco Animal Health Incorporated's Market Cap is $11.20B. At end of 2025 it was $11.24B. Ranked #857 of 3,121 in US market (top 27%), #589 of 1,658 on NYSE (top 36%), #41 of 266 in Pharmaceuticals, Biotechnology & Life Sciences (top 15%) by Market Cap.

Investment Metrics(as of 2026-09-18)

MetricValue
Size
Market Cap$11.20B
Revenue$5.02B
Net Income$-199M
Total Assets$13.56B
Net Assets$6.59B
Employees9,400
Value
P/B1.70x
P/S2.23x
EV/EBITDA18.84x
FCF Yield3.39%
Profitability
ROE-3.02%
ROA-1.47%
Op. Margin9.20%
Revenue Growth11.95%
Earnings Growth-145.85%
Financial Health
Debt Ratio105.84%
Total Debt$3.92B
FCF$379M
Cash$530M
Current Ratio2.05x
Net Debt/EBITDA4.38x
Performance
1Y Return17.36%
1M Return-8.51%
From 52W High-19.89%
1Y MDD-26.23%
Trading
Volume4,415,771 shares
Trading Value$99M
Per Share
EPS$-0.40
BPS$13.19

Company Info

CEO Mr. Jeffrey N. Simmons
Employees 9,400
HQ Indianapolis, United States

Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide. The company offers pet health products, such as parasiticides, vaccines, and therapeutics that protect pets from fleas, ticks, and internal parasites under the Seresto, K-9 Advantage, Advantix, and Advocate trademarks; prescription parasiticide products, an over-the-counter treatments for the prevention and elimination of fleas and ticks under the Credelio Family, Interceptor Plus, Drontal family, and Drontal Plus; vaccines portfolio that provides differentiated prevention coverage for a number of important pet health risks; and therapeutics portfolio for the treatment of pain, otitis, cardiovascular, and dermatology indications, as well as osteoarthritis for dogs and cats under the Galliprant trademark. It also provides farm animal products that help farmers improve animal health and wellbeing, and raise livestock, such as cattle, swine, and poultry. In addition, the company offers medicated feed additives, injectable antibiotics, vaccines, insecticides and enzymes, and others under the Rumensin, Baytril, and Experior trademarks for cattle; and under the Maxiban and Monteban trademarks for the control and prevention of intestinal disease in poultry. Further, it offers other pet health products for cats and dogs under the Atopica, Milbemax, Onsior, and Tru Family trademarks; and other farm animal products for poultry, cattle, and swine under the AviPro, Catosal, Denagard, Hemicell, Pulmotil, and Surmax tradmarks. The company sells its products to third-party distributors and independent retailers; and directly to farm animal producers and veterinarians. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Indianapolis, Indiana.